Structural studies of P-type ATPase-ligand complexes using an X-ray free-electron laser by Bublitz, Maike (Author) et al.
research papers
IUCrJ (2015). 2, 409–420 http://dx.doi.org/10.1107/S2052252515008969 409
IUCrJ
ISSN 2052-2525
BIOLOGYjMEDICINE
Received 21 January 2015
Accepted 8 May 2015
Edited by J. L. Smith, University of Michigan,
USA
‡ Current address: Institute of Biochemistry,
J. W. Goethe University, Max-von-Laue-Strasse
9, 60438 Frankfurt am Main, Germany.
§ Current address: Laboratory of Biomolecular
Research, Paul Scherrer Institute, 5232 Villigen,
Switzerland and Roche Pharma Research and
Early Development, Roche Innovation Center
Basel, Discovery Technologies, 4070 Basel,
Switzerland.
} Current address: BioXFEL STC, 700 Ellicott
Street, Buffalo, NY 14203, USA.
‡‡ Current address: Laboratory of
Molecular Biophysics, Uppsala University,
75 124 Uppsala, Sweden.
§§ Current address: Brookhaven National
Laboratory, PO Box 5000, Upton,
NY 11973-5000, USA.
}} Current address: Department of Cell and
Molecular Biology, Karolinska Institutet,
17 177 Stockholm, Sweden and Centre for
Structural Systems Biology, DESY Campus,
Hamburg, Germany.
††† Current address: Department of Biomedical
Sciences, University of Copenhagen,
Blegdamsvej 3B, 2200 Copenhagen, Denmark.
Keywords: XFEL; P-type ATPases; ligand
screening; serial femtosecond crystallography.
PDB reference: P-type ATPase–ligand complex,
4xou
Supporting information: this article has
supporting information at www.iucrj.org
Structural studies of P-type ATPase–ligand
complexes using an X-ray free-electron laser
Maike Bublitz,a*‡ Karol Nass,b Nikolaj D. Drachmann,a Anders J. Markvardsen,c
Matthias J. Gutmann,c Thomas R. M. Barends,b Daniel Mattle,a§ Robert L.
Shoeman,b R. Bruce Doak,b,d Se´bastien Boutet,e Marc Messerschmidt,e}Marvin M.
Seibert,e‡‡ Garth J. Williams,e§§ Lutz Foucar,b Linda Reinhard,a}} Oleg Sitsel,a
Jonas L. Gregersen,a Johannes D. Clausen,a,f Thomas Boesen,a Kamil Gotfryd,g
Kai-Tuo Wang,a††† Claus Olesen,a,f Jesper V. Møller,a,f Poul Nissena,h and Ilme
Schlichtingb
aDepartment of Molecular Biology and Genetics, Centre for Membrane Pumps in Cells and Disease – PUMPkin, Danish
National Research Foundation, Aarhus University, Gustav Wieds Vej 10c, 8000 Aarhus C, Denmark, bMax Planck
Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany, cRutherford Appleton Laboratory, ISIS
Facility, Chilton, Didcot OX11 0QX, England, dDepartment of Physics, Arizona State University, Tempe, AZ 85287, USA,
eLinac Coherent Light Source, LCLS, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park,
CA 94025, USA, fDepartment of Biomedicine, Aarhus University, Ole Worms Alle´ 3, 8000 Aarhus C, Denmark,
gDepartment of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen,
Denmark, and hDANDRITE, Nordic-EMBL Partnership for Molecular Medicine, Aarhus University, Gustav Wieds Vej
10C, DK-8000 Aarhus C, Denmark. *Correspondence e-mail: bublitz@em.uni-frankfurt.de
Membrane proteins are key players in biological systems, mediating signalling
events and the specific transport of e.g. ions and metabolites. Consequently,
membrane proteins are targeted by a large number of currently approved drugs.
Understanding their functions and molecular mechanisms is greatly dependent
on structural information, not least on complexes with functionally or medically
important ligands. Structure determination, however, is hampered by the
difficulty of obtaining well diffracting, macroscopic crystals. Here, the feasibility
of X-ray free-electron-laser-based serial femtosecond crystallography (SFX)
for the structure determination of membrane protein–ligand complexes using
microcrystals of various native-source and recombinant P-type ATPase
complexes is demonstrated. The data reveal the binding sites of a variety of
ligands, including lipids and inhibitors such as the hallmark P-type ATPase
inhibitor orthovanadate. By analyzing the resolution dependence of ligand
densities and overall model qualities, SFX data quality metrics as well as suitable
refinement procedures are discussed. Even at relatively low resolution and
multiplicity, the identification of ligands can be demonstrated. This makes SFX
a useful tool for ligand screening and thus for unravelling the molecular
mechanisms of biologically active proteins.
1. Introduction
Membrane protein crystallization and structure determination
are subject to multiple challenges, such as low yields, protein
instability and small crystals that are difficult to cryocool. The
production of well diffracting macroscopic crystals can be a
major bottleneck, and the optimization of crystals often
requires the time-consuming and expensive production of
large amounts of pure and stable protein samples. After the
successful determination of a first structure of a given target,
efforts often multiply in the quest to obtain further structures
with different bound compounds, such as stabilizers of
different conformations and/or compounds used for structure-
based drug development.
The emerging method of serial femtosecond crystallo-
graphy (SFX) at X-ray free-electron laser (XFEL) sources
enables high-resolution diffraction data collection from
nanocrystal or microcrystal suspensions injected into the
XFEL beam in their mother liquor at room temperature. This
circumvents the need for the time- and sample-demanding
optimization of large single crystals and their tedious handling
through cryoprotection, mounting and cryocooling required
for synchrotron-based approaches. We tested the feasibility of
SFX for the structure determination of ligand complexes of
membrane proteins using microcrystals of P-type ATPases
derived from both natural and recombinant sources bound to
different ligands.
P-type ATPases are ubiquitous, energy-dependent
membrane transporters that are present in all kingdoms of life
and constitute important drug targets both in humans and in
microbial pathogens owing to their vital role in the estab-
lishment and maintenance of transmembrane ion gradients
(Yatime et al., 2009; Bublitz et al., 2011). The study of the
interactions of ATPase with regulating ligands or inhibitors is
not only instrumental for the general understanding of
enzyme function (for example, vanadate or fluoride
compounds mimicking phosphoryl transition states, non-
hydrolyzable nucleotide analogues, lipids or stabilizers of
known catalytic conformations), but also for efforts in
structure-based drug development targeting P-type ATPase
activities in, for example, pathogens or cancer cells. For
example, tissue-specific inhibition of the sarco(endo)plasmic
reticulum Ca2+-ATPase SERCA is currently being clinically
tested as a strategy against hepatoma and prostate cancer by
induced apoptosis (Denmeade et al., 2003). In addition to
human targets such as SERCA, the Na+,K+-ATPase, the
gastric H+,K+-ATPase or heavy metal-transporting ATPases,
fungal plasma membrane H+-ATPases as well as P-type
ATPases from the malaria pathogen Plasmodium falciparum
are examples of targets for the development of new drugs
(Rottmann et al., 2010; Arnou et al., 2011). Here, we demon-
strate the potential of SFX for ligand characterization by
analyzing microcrystals of three different P-type ATPase–
ligand complexes: SERCA1a from rabbit leg muscle bound
to (i) the nonhydrolyzable ATP analogue 50-adenylyl(,-
methylene)diphosphonate (AMPPCP) and calcium (SERCA–
Ca2–AMPPCP; (ii) to the fluorescent ATP analogue 2
0,30-O-
(2,4,6-trinitrophenyl)adenosine 50-triphosphate (TNPATP)
and orthovanadate (SERCA–VO3–TNPATP); and (iii) as a
model protein for heavy metal-transporting ATPases, Shigella
sonnei Zn2+-ATPase ZntA (SsZntA) produced recombinantly
in Escherichia coli and bound to aluminium tetrafluoride
(SsZntA–AlF4).
SFX exploits the high intensity and femtosecond duration
of XFEL pulses for the acquisition of radiation damage-free
diffraction data in the so-called ‘diffraction before destruction’
approach (Chapman et al., 2011, 2014; Boutet et al., 2012). A
consequence of this approach is, however, that only a single
still image can be collected from each crystal, requiring a
steady supply of fresh crystals. This can be provided by means
of microjets (Weierstall et al., 2012, 2014; Sierra et al., 2012),
which allow the delivery of crystals to the XFEL interaction
region at room temperature and in their crystallization
medium, including lipidic mesophases such as sponge or cubic
phase media. Thus, diffraction data are collected in a serial
fashion, with each diffraction image derived from a different,
randomly oriented microcrystal. Owing to variations in the
size, diffraction properties, unit-cell parameters and mosaicity
of the single crystals, as well as fluctuations in the X-ray beam
parameters (pulse energy and spectral distribution) and
variations in how well the crystals intersect the X-ray focus at
the time of exposure, a large number of integrated diffraction
patterns are usually necessary to provide a sufficiently high
multiplicity of observations for each reflection to provide a
reliable conversion of the partial intensities to accurate
structure-factor amplitudes in a scheme called Monte Carlo
integration (Kirian et al., 2010, 2011). However, given the
difficulties in obtaining large quantities of membrane-protein
samples, this is not always possible (Kern et al., 2012, 2013;
Johansson et al., 2013), as was also the case for the data
presented here. We show that even at low resolution and with
low multiplicity, SFX data can provide valuable structural
information on a variety of ligands bound to a known struc-
ture, and we discuss general considerations for SFX data
collection and analysis.
2. Methods
2.1. Preparation and microcrystallization of P-type ATPases
All reagents and the samples of either purified protein or
membrane preparations were shipped to the LCLS and the
microcrystals were grown on site.
2.1.1. Ca2+-ATPase. 115 mg Ca2+-ATPase protein in rabbit
sarco(endo)plasmic reticulum vesicles, prepared according to
established procedures (Andersen et al., 1985), was used as the
starting material. For the Ca2–AMPPCP form, the ATPase
was solubilized in a buffer consisting of 94.6 mMMOPS/KOH
pH 6.8, 80 mM KCl, 20% glycerol, 2.5 mM MgCl2, 0.88 mM
AMPPCP, 8.87 mM CaCl2, 22.3 mg ml
1 octaethylene glycol
monododecyl ether (C12E8). The solubilized protein at a
concentration of 10 mg ml1 was mixed in equal amounts with
crystallization buffer (21.5% polyethylene glycol 6000,
200 mM sodium acetate, 15% glycerol, 4% tert-butanol, 5 mM
-mercaptoethanol) in batches of 50–100 ml in PCR reaction
tubes. Microcrystals with approximate dimensions of 10 5
5 mm grew within 2–3 d at 19C.
For crystallization of the SERCA–VO3–TNPATP complex,
the protein was prepared as above, apart from pre-incubation
for 1.5 h with sodium orthovanadate before the addition of
TNPATP and detergent solubilization. The final buffer
composition was 100 mM MOPS/KOH pH 6.8, 80 mM KCl,
20% glycerol, 0.25 mM MgCl2, 1.5 mM EGTA, 1 mM VO4
3,
0.4 mM TNPATP, 22.3 mg ml1 C12E8. Batches of 20 ml
containing equal amounts of protein solution (10 mg ml1)
and crystallization buffer (28% polyethylene glycol 2000
monomethyl ether, 10% glycerol, 100 mM NaCl, 3% tert-
butanol) were mixed and rod-shaped microcrystals of
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approximately 2  2  10–50 mm in size grew within 3 d at
19C. The batches, yielding a total volume of 8 ml for
SERCA–Ca2–AMPPCP and 4.27 ml for SERCA–VO3–
TNPATP, were combined, yielding microcrystalline sediments
constituting 30–40% of the batch volume for SERCA–Ca2–
AMPPCP and 80% of the batch volume for SERCA–VO3–
TNPATP. The combined batch was vortexed for 3.5 min in the
case of SERCA–VO3–TNPATP to break the long needle-
shaped crystals into shorter pieces, and all samples were
filtered (see below) immediately before data collection.
2.1.2. Zn2+-ATPase. ZntA from S. sonnei (SsZntA) was
expressed in E. coli C41 cells induced with 1 mM IPTG at
20C. The cells were resuspended on ice in 50 mM Tris–HCl
pH 7.6, 200 mM KCl, 20% glycerol, 5 mM -mercaptoethanol
(BME), 2 mg ml1 DNase I and one protease-inhibitor tablet
(Sigma) per 6 l of culture and were lysed with a high-pressure
homogenizer at 138 MPa. Cell debris was removed by
centrifugation at 20 000g and 4C for 45 min, and membranes
were isolated by ultracentrifugation at 250 000g and 4C for
5 h and resuspended on ice in 15 ml 20 mM Tris–HCl pH 7.6,
200 mM KCl, 20% glycerol, 5 mM BME, 1 mM MgCl2 per
gram of membrane pellet. The membrane proteins were
solubilized for 1 h at 4C in 1%(w/v) C12E8 and unsolubilized
material was removed by ultracentrifugation at 250 000g and
4C. Solid KCl and imidazole were added to final concentra-
tions of 500 and 50 mM, respectively, and the solution was
applied onto a pre-packed 5 ml Ni2+–NTA column followed by
a Superose 6 10/300 GL gel-filtration column using buffer D
(20 mM MOPS–KOH pH 6.8, 80 mM KCl, 20% glycerol,
5 mM BME, 1 mM MgCl2, 0.15 mg ml
1 C12E8). The purified
protein was concentrated to 8 mg ml1 using a Sartorius
Vivaspin 20 centrifugal concentrator (with molecular-weight
cutoff 50 kDa) and frozen until further use.
SsZntA was crystallized in batch mode in the presence of
2 mM AlF4
, 2 mM EGTA and 10 mM N,N,N0,N0-tetrakis-2-
pyridylmethyl-ethylenediamine. Prior to crystallization, 72
CMC of C12E8 was added to the protein, and batches of 50 ml
protein with 50 ml precipitant solution (100 mMMOPS pH 6.8,
0.5M lithium acetate, 15% PEG 2K MME, 10% glycerol, 3%
tert-butanol, 5% d-sorbitol, 5 mM BME) were incubated at
19C. Rod-shaped crystals of 5 mm in length were fully grown
within 2 d after setup, but in clusters surrounded by amor-
phous precipitate. Therefore, before injection, the micro-
crystal suspension of total volume 1.3 ml was repeatedly
passed through a 19 mm long G.27 syringe needle with an
inner diameter of 0.210  0.019 mm (BD Biosciences) to
homogenize the crystal suspension.
2.2. Injection of microcrystals into the pulsed XFEL beam
Microcrystal suspensions were kept at 18C and filtered
through a 20 mm inline stainless-steel filter. The microcrystals
were injected with an HPLC system (Shimadzu Biotech,
Duisburg, Germany) into the vacuum chamber in an 5 mm
wide liquid jet produced with a gas dynamic virtual nozzle
(GDVN; DePonte et al., 2008) housed in a liquid injector
(Weierstall et al., 2012) as described previously (Chapman et
al., 2011; Boutet et al., 2012). In general, the sample flow rate
was 12–30 ml min1. A protocol for alternating sample and
water flow through the jet capillary proved to be useful to
prevent nozzle clogging, thus maintaining a constant hit rate
and diffraction quality.
2.3. Collection of diffraction data
An average of 3.75 mJ was delivered in each 50 fs pulse of
6.0 keV X-rays. The beamline transmission was 40%. Single-
pulse diffraction patterns were recorded at 120 Hz using a
Cornell–SLAC pixel-array detector (CSPAD; Hart et al., 2012)
positioned in the microfocus chamber of the CXI instrument
at a distance of 130 mm from the interaction region.
2.4. Data processing, phasing and refinement
Raw data streams from the CXI instrument were pre-
analysed using the CASS software suite (Foucar et al., 2012).
After offset-correcting the individual images and masking bad
pixels based upon the noise of the individual pixels, Post-
Processor with ID 208 was used to identify Bragg spots
(Foucar et al., to be submitted). A selected background size of
4  4, which resulted in a box size of 9  9 pixels, was used
with a local signal-to-noise ratio of 4. The minimum number of
pixels contributing to a Bragg spot was set to three and the
threshold to identify the highest pixel value within the box was
set to 400 ADU. Identified crystal hits were saved in HDF5
format for indexing and Monte Carlo merging using CrystFEL
(White et al., 2012). Merged structure factors were exported in
CCP4 format for structural analysis.
Phases for SERCA–Ca2–AMPPCP and SERCA–VO3–
TNPATP were obtained by molecular replacement (MR) with
Phaser (McCoy et al., 2007) using the PHENIX AutoMR
implementation (Adams et al., 2010). The search models were
PDB entry 3n8g for SERCA–Ca2–AMPPCP and PDB entry
3n5k for SERCA–VO3–TNPATP (Bublitz et al., 2013), with all
ligands removed prior to MR procedures. In order to diminish
the model bias from the Ca2+ and AMPPCP ligands which had
been included in the refinement of the isomorphous 3n5k
search model, we carried out a simulated-annealing (500 K)
refinement against the original data and reset all B factors to
the average value before using the model in the molecular-
replacement procedure. All refinements were carried out
using PHENIX (Adams et al., 2010). SERCA–Ca2–AMPPCP
was first refined by rigid-body refinement, with 13 rigid groups
comprising the cytosolic A, P and N domains as well as one
separate group for each of the ten transmembrane helices. The
output model from the 13-group rigid-body refinement was
then used as an input model for refinement of coordinates and
B factors for all 7671 (SERCA alone, without ligands) or 7706
(including nucleotide and bound ions) atoms. To avoid over-
fitting, we included an optimization of the restraint weights for
both geometry and B factors during refinement, and we used
the original molecular-replacement model 3n8g as a reference
for the generation of dihedral restraints, except for the final
refinement round. Map files were generated with FFT (Read
& Schierbeek, 1988) or PHENIX (Adams et al., 2010), and
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figures were prepared with PyMOL (Schro¨dinger). No ligands
were included in either the molecular-replacement or the
initial refinement runs in order to obtain bias-free mFo  DFc
difference electron-density maps. Where applicable, the Rfree
flags were copied from the data set against which the search
model had originally been refined to ensure an independent
cross-validation set. The SERCA–VO3–TNPATP structure
was refined by rigid-body strategies only, using the same 13
rigid groups as above.
For the generation of a data set with scrambled reflection
intensities, reflections (and their sigma values) were sorted by
resolution, put into groups of ten and then randomly scram-
bled, but keeping the Rfree flags associated with the original
index hkl. To this end, the data were sorted by resolution using
SFTOOLS (Hazes, unpublished work) and grouped into bins
of ten reflections. The reflections were then scrambled
randomly within a bin. In this way, the dependence of the
intensity statistics on the resolution was preserved as much as
possible while still scrambling the intensities themselves. The
original reflections at a resolution higher than 5.8, 4.6, 4.0, 3.6,
3.4, 3.2, 3.0 or 2.9 A˚ were then replaced with the scrambled
data (CAD, MTZUTILS; Winn et al., 2011), yielding a set of
‘chimeric’ data sets, all extending to 2.8 A˚ resolution but only
containing real data up to the given cutoff.
3. Results
3.1. Microcrystallization
Since the growth of macroscopic crystals has been the most
common approach to obtain high-resolution X-ray diffraction
data in the past decades, procedures aimed at maximizing
crystal size have been well described (Bergfors, 2009; Chayen
& Saridakis, 2008; Doublie´, 2007). This is, however, not the
case for protocols aiming to grow large amounts of uniformly
sized microcrystals. The following section describes in detail
how we established a robust and reproducible batch micro-
crystallization procedure for our P-type ATPase samples.
Liquid microjet injection requires relatively large sample
volumes, which is why we used batch approaches for crystal-
lization. In order to establish a reproducible production of
batches with uniformly sized microcrystals, we started from
the vapour-diffusion hanging-drop crystallization conditions
previously optimized for macroscopic crystals. In the case of
SERCA–Ca2–AMPPCP, these macrocrystals had been used
for the original structure determination (Sørensen et al., 2004),
whereas macrocrystals of SERCA–VO3–TNPATP and ortho-
vanadate and of SsZntA–AlF4 had, at the time of our SFX
experiments, both yielded diffraction to about 4 A˚ resolution
at a synchrotron and no structures had been published. We
systematically explored the variation of all components of the
precipitant solutions (PEG, salt, glycerol, reducing agent and
alcohol type and concentrations), as well as varying the ligand
concentrations, batch sizes and batch-mixing procedures
(manual ‘flipping’ versus short vortexing). We also tested the
addition of immersion oil either directly on top of the batch
mixture or inside the lid of the reaction tube, since hanging-
drop crystallization of most P-type ATPases in our hands
strongly depended on the use of immersion oil to seal the
wells. Furthermore, we tested the crystallizability of SERCA
preparations from rabbit sarcoplasmic reticulum, which had,
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Figure 1
Diffraction pattern, electron density and structure of SERCA–Ca2–
AMPPCP. (a) Representative diffraction pattern of SERCA–Ca2–
AMPPCP microcrystals. The boxed inset shows a strong Bragg spot at
2.8 A˚ resolution {Miller index [31, 15, 24], hI/(I)i = 8.4}. (b) Left,
overall 2mFo  DFc electron-density map (contoured at 1.0) after final
refinement including coordinates and B factors for all atoms and data to
2.8 A˚ resolution; right, molecular model, including ten transmembrane
helices and cytoplasmic N (nucleotide binding), P (phosphorylation) and
A (actuator) domains. The 13 structural segments initially refined as rigid
groups are shown in different colours. Ligand-binding regions are
indicated by numbers: 1, AMPPCP; 2, Ca2+ ions; 3, lipid.
for the purpose of a larger protein yield
at the cost of slightly lower purity, not
been purified by deoxycholate (DOC)
extraction, as is usually performed
when following established procedures
(Møller et al., 2002). In all cases, the
final conditions that yielded the highest
density of the most uniformly sized
microcrystals in 30–100 ml batches were
astonishingly similar to the starting
conditions for growing macrocrystals in
hanging drops: essentially, only the
concentration of the precipitating agent
needed to be increased (by approxi-
mately 30 and 170% for SERCA–VO3–
TNPATP and SERCA–Ca2–AMPPCP,
respectively), and for SsZntA–AlF4 the
alcohol additive was changed from
MPD to t-BuOH (see Supplementary
Table S1). Varying other parameters
such as salt or glycerol concentration as
well as the presence or absence of
immersion oil or omitting the DOC
extraction step had surprisingly little
effect on crystal size. The only notable
factors besides the precipitant concen-
tration were the mixing procedure
(thorough manual ‘flipping’ of the tubes
was superior to superficial mixing or
vortexing, the former of which led to a
non-uniform size distribution of crystals
and the latter of which introduced foam
in the detergent-containing conditions),
and there was an inverse correlation of
optimal glycerol and PEG concentra-
tions: higher PEG concentrations
yielded more uniform batches in
combination with lower glycerol, also
owing to the avoidance of the phase
separation which occurred at very high
PEG and glycerol concentrations.
For the measurements at the LCLS,
frozen microsomes or protein samples
were shipped to SLAC National Accel-
erator Laboratory, where the proteins
were crystallized on-site before data
collection. Single batches were set up in
volumes of 30–100 ml, grew within 1–2 d
(which is consistently faster than
growing macrocrystals, which typically need 1–2 weeks to
reach final size) and manually combined immediately before
data collection. SsZntA–AlF4 microcrystals grew as clusters
embedded in amorphous precipitate, which were homo-
genized by passing the sample repeatedly through a 400 um
syringe needle before data collection. Microcrystals of
SERCA–VO3–TNPATP grew as long needles of varying
lengths and diameters, which were mechanically homogenized
by vortexing before data collection with no apparent loss of
diffraction quality.
3.2. Data collection
SFX data were collected in June 2012 (proposal L597) using
the microfocus chamber of the CXI instrument at the LCLS as
described previously (Boutet et al., 2012). The microcrystalline
research papers
IUCrJ (2015). 2, 409–420 Bublitz et al.  XFEL studies of P-type ATPase–ligand complexes 413
Table 1
Data-collection and refinement statistics.
Values in parentheses are for the outer shell except where indicated otherwise.
SERCA–Ca2–AMPPCP SERCA–VO3–TNPATP SsZntA–AlF4
Data-collection and processing
X-ray energy (keV) 6 6 6
Collected frames 761730 1371609 280281
Diffraction hits† 23016 (3.0) 83934 (6.1) 16358 (5.8)
Indexed frames‡ 4069 (17.8) 4910 (5.8) 55 (0.3)
Space group C2 P4212 P422
a, b, c (A˚) 162, 76.3, 151 268, 268, 114.5 58, 58, 320
, ,  () 90, 109.0, 90 90, 90, 90 90, 90, 90
Highest resolution observed (A˚) 2.8 4 4
Resolution range for processing (A˚) 59.9–2.8 (2.9–2.8) 57.25–5.00 (5.18–5.00) n.a.§
Unique reflections 42416 (3652) 18601} (1813) n.a.§
Multiplicity 17.3 (4.2) 124 (117) n.a.§
hI/(I)i 1.13 (0.39) 2.03 (0.34) n.a.§
Rsplit†† (%) 62.3 (538) 22.5 (424) n.a.§
CC1/2 0.70 (0.03) 0.97 (0.16) n.a.§
CC* 0.90 (0.25) 0.99 (0.53)
Anomalous CC‡‡ n.a. 0.06 (0.03) n.a.§
Completeness (%) 98.1 (85.5) 99.91 (100) n.a.§
Molecular replacement
Search-model PDB code§§ 3n8g 3n5k
Rotation-function Z-score
(ensemble 1/2)
8.4 2.3/1.8
Translation-function Z-score
(ensemble 1/2)
10.6 11.5/20.4
Log-likelihood gain 4295 991
Refinement
Resolution (A˚) 60–2.80 (2.91–2.80)
No. of reflections 41471 (3500)
Final Rcryst/Rfree (%) 30.4/34.3 (47.5/49.9)
No. of non-H atoms
Protein 7671
Ca2+ 3
K+ 1
AMPPCP 31
Total 7706
R.m.s. deviations
Bonds (A˚) 0.006
Angles () 0.762
Average B factors (A˚2)
N domain 97.7
P domain 97.6
A domain 114
TM domain 130.3
Ca2+ 113
K+ 91.0
AMPPCP 88.6
Ramachandran plot
Most favoured (%) 95.1
Allowed (%) 4.4
† Numbers in parentheses are the percentage of the total collected frames. ‡ Numbers in parentheses are the
percentage of indexed frames. § The Zn2+-ATPase data set was not merged because the number of indexed patterns
was too low to obtain meaningful merged data. } The according numbers of unique reflections when merged with
Friedel pairs treated as separate reflections is 31 576 (3262). †† Rsplit is defined in CrystFEL as the R factor between
data sets calculated from two randomly chosen halves of the data, corrected for the decrease in multiplicity caused by
dividing the data into halves: Rsplit = ð1=21=2Þð
P jIAhkl  IBhkl j= 12
P jIAhkl þ IBhkl jÞ. ‡‡ Determined from processing the data
set with separated Friedel mates. §§ See x2 for details of how the search models were prepared to remove model
bias.
suspensions were kept at 18C during data collection using a
temperature-controlled rotating syringe pump that also
prevented crystal settling (Lomb et al., 2012). The micro-
crystals were injected into the XFEL beam using a liquid
microjet injector (Weierstall et al., 2012). The high concen-
trations of high-molecular-weight polyethylene glycols and
glycerol in all samples led to occasional clogging of the
injection nozzle. This problem was overcome by alternating
water and sample injection at 5–10 min intervals. SFX
diffraction data were collected at 6 keV photon energy
(2.07 A˚ wavelength) at the full 120 Hz repetition rate of the
LCLS using a CSPAD detector (Hart et al., 2012). All
diffraction images were saved, irrespective of whether or not
they contained diffraction peaks. Crystal hits were identified
by CASS (Foucar et al., 2012) as images containing more than
ten Bragg reflections. Hits were indexed, integrated and
merged with the CrystFEL software suite (White et al., 2012).
The detector geometry was calibrated using a lysozyme SFX
data set collected immediately prior to P-type ATPase data
collection (data not shown). We collected three SFX data sets
from P-type ATPase microcrystals: rabbit SERCAwith bound
calcium ions and AMPPCP (SERCA–Ca2–AMPPCP),
SERCA with bound orthovanadate and TNPATP (SERCA–
VO3–TNPATP) and S. sonnei Zn
2+-ATPase SsZntA bound to
the inhibitor aluminium tetrafluoride (SsZntA–AlF4).
3.3. SERCA–Ca2–AMPPCP: refinement
SFX diffraction images of microcrystals of SERCA–Ca2–
AMPPCP showed diffraction beyond 3 A˚ resolution (Fig. 1a).
This is not on a par with the 2.5 A˚ resolution diffraction limit
of the corresponding cryocooled macrocrystals at a synchro-
tron (Sørensen et al., 2004), and may be owing to a narrow
time window for optimal microcrystal quality, in which an
increase in the age of the crystal sample of only 24 h already
led to weaker diffraction and a higher number of overlapping
diffraction patterns, indicating crystal clustering. We recorded
760 000 images, of which 23 000 (3%) were identified as
hits containing a diffraction pattern; of these, 4069 (18%)
could be indexed in C2, the same space group as macroscopic
SERCA–Ca2–AMPPCP crystals. The merged data have an
overall 17-fold multiplicity of observation. This is extremely
low for SFX data analysed by CrystFEL, which uses Monte
Carlo methods to obtain scaled and merged intensities from
the still images, averaging out all fluctuations in the data-
acquisition process. One has to bear in mind, however, that in
SFX multiplicity refers to the number of partial intensity
measurements and not of fully integrated intensities. In line
with this low multiplicity, the signal-to-noise ratio drops to
1.47 at 4 A˚ resolution (Table 1 and Supplementary Table S2).
However, it must also be considered that the signal-to-noise
ratio as defined by CrystFEL is based on the standard devia-
tions of the sets of individual observations of a reflection
themselves, not on the signal-to-noise ratios of merged, scaled
and averaged diffraction peaks representing fully recorded
reflections.
Nevertheless, we obtained a clear solution by MR using the
synchrotron structure (PDB entry 3n8g; Bublitz et al., 2013)
with all ligands removed as a search model (see x1 for details;
Fig. 1b). An initial rigid-body refinement with increasing
numbers of rigid groups was carried out in PHENIX using
data to 4 A˚ resolution, and finally an all-atom and individual
B-factor refinement yielding a decrease in the model R factors
(Fig. 2a). In order to determine the effective resolution limit of
the data, we then carried out successive refinement runs with a
stepwise inclusion of higher resolution shells, as suggested in
recent work by Karplus & Diederichs (2012), Steuber et al.
(2014) and Hattne et al. (2014) (Fig. 2b). This analysis revealed
an improvement of model R factors upon the inclusion of
higher resolution data, justifying an extension of the data set
to 2.8 A˚ resolution. Only the resolution range between 3.6 and
3.4 A˚ led to increased R factors, most likely owing to high
solvent background scattering in this resolution range. The
strategy of expanded resolution led to a final refined model
with Rwork and Rfree values of 30.6 and
34.4%, respectively, at 2.8 A˚ resolution.
As a control for the significance of
the information in the low-multiplicity
2.8 A˚ resolution data, we generated
data sets with randomly scrambled
reflection intensities ranging from a
wide shell of scrambled intensities (5.8–
2.8 A˚) to a narrow shell (2.9–2.8 A˚) at
high resolution only. We compared the
statistics of refinement against these
data with those derived from refinement
against the unperturbed data. As seen in
Fig. 3, the introduction of the scrambled
data was clearly detectable as a devia-
tion point in Rfree values, even if only
the highest resolution shell between 2.9
and 2.8 A˚ had been scrambled. This
shows that the SFX intensities contain
consistent signal. As a further analysis
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Figure 2
Rwork and Rfree values resulting from different refinement strategies. (a) R values after refinement
with increasing numbers of parameters, including data to 4.0 A˚ resolution. (b) Differences in R
values after refinement (all atom coordinates, individual B factors) depending on the chosen high-
resolution data cutoff. Models were refined in parallel to both the lower and the higher resolution
cutoff and the R values were compared at the lower cutoff. The range of lower data quality between
3.6 and 3.4 A˚ is probably caused by high background scattering owing to the solvent.
of the quality of the higher resolution data, we performed
refinement of scrambled models to challenge the benefit and
phase bias of a pre-refined model. Here, however, we found
that the model refinement could not converge towards an
improved model. Thus, the higher resolution data only
improve map features when high-quality prior phases are
available.
3.4. SERCA–Ca2–AMPPCP: analysis of bound ligands
After rigid-body refinement at low resolution, the
mFo  DFc difference map of the refined ligand-free SERCA
model already revealed a prominent peak at the nucleotide-
binding site (site 1 in Fig. 1b and Fig. 4) consistent with the
presence of bound Ca2+–AMPPCP in the microcrystals and
overlapping very accurately with the position of the Ca2+–
AMPPCP ligand in the superposed synchrotron-derived
model (Fig. 4, upper panels). As to be expected for valid data,
the connectivity and the signal level of the electron density
improved with increasing resolution, with all moieties of the
ligand reaching a level of >3 at 3.2 A˚ resolution and levelling
off beyond 3 A˚ resolution (Supplementary Fig. S3). We were
also able to detect the two bound Ca2+ ions located at the
intramembranous binding sites I and II (site 2 in Fig. 1b, lower
panels of Fig. 3 and Supplementary Fig. S4). Importantly, the
two calcium ions in the difference maps were only apparent
when all atom coordinates and B factors were refined and data
at 3.5 A˚ resolution or beyond were included in the refinement.
The mFo  DFc difference electron-density map further-
more revealed an additional ligand peak, which could be
assigned to a bound phospholipid head group at the
membrane interface between transmembrane helices M2, M6
and M9 (site 3 in Fig. 1b and Figs. 5a and 5b). The position of
the peak coincides with a lipid head group modelled into
previous structures of SERCA in the
Ca2E1 state (Toyoshima et al., 2011) and
the related Ca2+-occluded Ca2E1–
ADP–AlF4
 complex (Picard et al., 2007;
Fig. 5a). Interestingly, this groove was
recently identified as the binding site
for sarcolipin, a natural regulator of
SERCA activity (Winther et al., 2013;
Toyoshima et al., 2013; Fig. 5b),
pinpointing this region as a putatively
generic modulatory site for lipids or
regulatory proteins during the E1–
Ca2E1P transition of the ATPase
(Drachmann et al., 2014).
The overall differences between the
final room-temperature FEL-derived
and the synchrotron-derived structure
are small; the r.m.s.d. over all atoms is
0.46 A˚. The average B factor of the FEL
structure is slightly higher but quite
comparable to that of the synchrotron
structure (average B of 114 A˚2 for 2.8 A˚
resolution refinement versus 97 A˚2 for
2.6 A˚ resolution refinement).
3.5. SERCA–VO3–TNPATP
Microcrystals of SERCA–VO3–
TNPATP diffracted to 4 A˚ resolution
(Supplementary Fig. S5a). We collected
1 371 609 images, 83 934 (6.1%) of
which were classified as hits; 4910 of
these (5.8%) could be indexed, notably
revealing a crystal form with a different
space group from that of macrocrystals
grown under similar conditions (SFX,
P4212, a = b = 268, c = 114.5 A˚,  =  = 
= 90; synchrotron, P21, a = 130, b = 95,
c = 135 A˚,  = 107). MR was success-
fully carried out with an aluminium
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Figure 3
Plot of free R factor against resolution after refinement (all atom coordinates, individual B factors)
to 2.8 A˚ resolution against the original data set (dashed black lines) and hybrid data sets (red lines)
with scrambled intensities. The arrows indicate the beginning of the scrambled data at (a) 5.82 A˚,
(b) 4.62 A˚, (c) 4.04 A˚, (d) 3.67 A˚, (e) 3.41 A˚, ( f ) 3.21 A˚, (g) 3.04 A˚ and (h) 2.91 A˚. These cutoffs
were chosen in accordance with the resolution shells used by phenix.refine to calculate the Rfree
values of the model.
tetrafluoride-stabilized structure (PDB entry 3n5k) with the
ligands omitted, which we anticipated to be in the same
conformational state as the orthovanadate-bound structure.
After comparing R values from rigid-body refinement at
stepwise increasing resolution, we set the ‘effective’ high-
resolution cutoff for this data set to 5 A˚ (see Supplementary
Fig. S6).
After rigid-body refinement of the MR-derived initial
model (ligand-free; see x2 for details) including data to 5 A˚
resolution, we calculated an mFo  DFc difference map. The
two strongest positive peaks (12 and 10) were observed
at the phosphorylation sites of the two molecules in the
asymmetric unit, i.e. coinciding with the anticipated site of
vanadate binding. Furthermore, weaker peaks (4.9 and
4.5) were apparent for the bound TNPATP nucleotide
analogue in both molecules in the asymmetric unit. We also
additionally found a weak positive peak (3.4) overlapping
with the vanadate position in one of the two molecules in an
anomalous difference Fourier map calculated to 5 A˚ resolu-
tion. However, neither this peak nor several other peaks in the
anomalous difference map which could be assigned to over-
lapping positions of S atoms in the model clearly stood out
from the noise level, indicating that a higher multiplicity or
higher resolution is required for a robust anomalous signal for
moderate anomalous scatterers to emerge from SFX data.
Nevertheless, this example shows that it is possible to identify
the signal of TNPATP and vanadate as ligands with SFX data
extending to only 5 A˚ resolution with a multiplicity of 120.
During the preparation of this manuscript, higher resolution
synchrotron data were obtained for the SERCA–VO3–
TNPATP complex, confirming the overall conformation of the
enzyme and the binding sites of both vanadate and TNPATP
in our low-resolution structure (Clausen et al., manuscript in
preparation).
3.6. SsZntA–AlF4
We started our microcrystallization attempts based on the
conditions for macroscopic Zn2+-ATPase crystals with an
elongated hexagonal plate-like morphology: approximately
100 mm in the largest dimension but only a few micrometres in
thickness. The microcrystals of SsZntA–AlF4 were approxi-
mately 5 mm long rods that diffracted to 4 A˚ resolution
(Supplementary Fig. S5b). We collected 280 000 images,
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Figure 4
Electron density for SERCA ligands at different resolutions. Upper panels depict the nucleotide-binding site (region 1 in Fig. 1b) and lower panels the
Ca2+-binding site (region 2 in Fig. 1b). Green mesh,mFoDFc map after refinement without any ligands contoured at 3.0. Refinements with resolution
cutoffs lower than 3.4 A˚ were restricted to 13 rigid-body groups, whereas refinements including data to 3.4 A˚ resolution or higher included individual
atom coordinates and B factors. The expected ligand positions are superposed on all panels for Ca2+ and on the last panel for Ca2+–AMPPCP (PDB entry
3n8g). For a quantification of the density coverage around the ligands, see Supplementary Figs. S3 and S4.
16 358 of which were classified as hits, but only 55 of these
(0.3%) could be indexed. Interestingly, the microcrystals again
displayed a new space-group symmetry (SFX, P422, a= b = 58,
c = 320 A˚,  =  =  = 90; synchrotron, C2221, a = 77, b = 83,
c = 320 A˚,  =  =  = 90). The long c axis of 320 A˚ however
probably caused the very low indexing rate owing to closely
adjacent reflections on the diffraction images. By performing a
six-dimensional search to determine the optimal values for a,
b, c, ,  and , we attempted to determine a range of values
which led to the highest indexing rates, but with a maximum of
only 55 indexed images the data set did not support successful
phasing by molecular replacement. Recently, higher resolution
synchrotron data were obtained from macrocrystals of the
Zn2+-ATPase and the resulting crystal structures are discussed
elsewhere (Wang et al., 2014).
4. Discussion
SFX experiments exploiting the femtosecond pulse duration
and outstanding peak brilliance of XFELs hold great promise
for challenging crystal structure determinations. Here, we
demonstrate the feasibility of this method for ligand screening,
testing different ligand complexes of microcrystalline P-type
ATPases from native and recombinant sources.
The resolution of the collected SFX data for SERCA–Ca2–
AMPPCP was slightly lower than that of synchrotron data
from macrocrystals (Sørensen et al., 2004), likely owing to a
small time window for optimal microcrystal quality. Only a
24 h difference in the age of the crystal sample led to weaker
overall diffraction and a higher number of overlapping
diffraction patterns, indicating crystal clustering. Optimization
of the crystallization conditions is therefore likely to allow a
further improvement of the observed diffraction and should
be a general focus when growing microcrystals. Furthermore,
the fact that in all three cases the microcrystals grew much
faster than corresponding macrocrystals accommodates a
ligand-screening scenario well. In other cases we did not
succeed, such as for Na+,K+-ATPase crystals, for which
synchrotron radiation provided a 4.3 A˚ resolution data set
(Nyblom et al., 2013). For those crystals we observed only
20 A˚ resolution at best from microcrystals (data not shown).
Nevertheless, valid structural information can be extracted
from SFX data even at resolution ranges where hI/(I)i is
below 1 or CC1/2 approaches zero (Fig. 5) if good phases are
available. CrystFEL applies a global resolution cutoff to all
frames. If the data set contains diffraction patterns of weakly
or poorly diffracting crystals, this can result in the inclusion of
very weak high-resolution intensities. This not only contri-
butes to the low hI/(I)i values mentioned above, but may also
affect the intensity distribution and Wilson plot (see Sawaya et
al., 2014). CrystFEL uses Monte Carlo methods to obtain
merged intensities. Their accuracy strongly depends on the
number of observations to average out the various fluctuations
in the individual measurements. Indeed, very high multi-
plicities were required for de novo phasing, which requires
highly accurate structure-factor measurements (Barends et al.,
2014). However, the accuracy of the measured intensities does
not have to be very high to observe features in a phased
Fourier map (possibly even an anomalous map). Almost
counterintuitively, Fourier maps can show details that one
would not expect to be able to see given the accuracy of the
data (Henderson & Moffat, 1971). This is the reason why the
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Figure 5
Electron density of SERCA ligands. A peak of 6 in the mFo  DFc OMIT map after refinement without ligands (all atom coordinates, individual B
factors) against data to 2.8 A˚ resolution overlaps with (a) a phosphatidylcholine modelled in the E1–ADP–AlF4 form (stick representation; PDB entry
2zbd; Toyoshima et al., 2004) and (b) the N-terminal part of regulatory sarcolipin (grey cartoon; PDB entry 4h1w; Winther et al., 2013). (c) mFo  DFc
OMIT map (green, 3.0; red, 3.0) calculated to 5 A˚ resolution at the vanadate- and TNPATP-binding sites. The side chain of the catalytic residue
Asp351 is shown in stick representation.
high-resolution data of the SERCA–Ca2–AMPPCP complex
provide useful information despite their poor hI/(I)i value
and their low multiplicity of measurements [in our case
hI/(I)i and multiplicity in the highest resolution shell are as
low as 0.39 and 4.2, respectively; Table 1].
Importantly, we also demonstrate that the inclusion of weak
observations contributes favourably to model refinement
compared with simulated random data (Fig. 3), similar to the
findings of a recent analysis by Evans & Murshudov (2013).
We therefore suggest that once the initial phases have been
obtained, the ‘effective resolution’ should be determined
empirically for each data set by the stepwise inclusion of
higher resolution shells, comparing R values after a standar-
dized refinement protocol. The number of refined parameters
can then be adapted to the available amount of data for the
determined resolution range. If known ligands are available,
the analysis of unbiased difference electron-density maps of
stepwise-increased resolution cutoffs can give valuable infor-
mation about the ‘effective resolution’. In our test case of
SERCA–Ca2–AMPPCP, we observe a levelling off of the
density signal between 3.0 and 2.8 A˚ resolution, meaning that
from some point within this range there is no additional signal
available. However, since we had a clear indication of few but
strong diffraction spots at 2.8 A˚ resolution (see Fig. 1a), we
decided to include data to 2.8 A˚ resolution even though the
high-resolution shell has poor crystallographic precision
indicators such as an hI/(I)i of only 0.39, an Rsplit of >500%
and a CC1/2 heading towards zero. Nevertheless, 18.3% of the
data do still have an hI/(I)i value above 1 in the highest
resolution shell. Rsplit and CC1/2 have been suggested as useful
indicators of significant information content of crystallo-
graphic data (Karplus & Diederichs, 2012), and other SFX
studies report values of between 53% and 162% for Rsplit and
0.27 and 0.37 for CC1/2 in the highest resolution shells (Sawaya
et al., 2014; Johansson et al., 2013; Liu et al., 2013). In our case,
the CC1/2 value reaches a minimum at 3.0 A˚ (Fig. 6). When
calculating the actual significance of CC1/2 values with respect
to the number of reflections in the highest resolution shell for
data truncated at 3.0, 2.9 and 2.8 A˚ resolution, we find that the
Student’s t-test P-values oscillate between significance at the
1% level and the 7% level (P = 0.0675 at 3.0 A˚, P < 0.00001 at
2.9 A˚ and P = 0.0698 at 2.8 A˚). Johannsson et al. (2014) report
a smooth decline of CC1/2 to zero, making it similarly difficult
to determine a definite limit of significance. They finally used a
decrease in the quality of electron density as an indicator to
truncate the data at a CC1/2 of 0.3. Since in our case the ligand
electron-density levels do not decline (Fig. 4 and Supple-
mentary Figs. S3 and S4) even at a CC1/2 of 0.08 in the 2.9–
2.8 A˚ shell, we decided to include all data showing any weak
indication of significance. In addition, both the Rfree values
(Fig. 2b) and the scrambled data comparisons (Fig. 3) confirm
that the inclusion of these weak data did introduce detectably
more signal than noise. Specifically, if we had not included
data to 2.8 A˚ resolution it would not have been possible to
reliably detect the two bound Ca2+ ions in the structure. If
good phases are available, the information content of differ-
ence Fourier maps can be much higher than immediately
expected from the data quality. This is typically the case for,
e.g., ligand-soaked crystals where a higher resolution template
structure is available, or when averaging by non-
crystallographic symmetry can be applied.
Another demonstration of the information available from
SFX data even at low resolution is the fact that we observed a
number of peaks in a phased anomalous difference map
calculated with the 5 A˚ resolution SERCA–VO3–TNPATP
data that could be assigned to anomalous scatterers. Even
though the map was also very noisy, we assume that a higher
redundancy would have been sufficient to provide a robust
anomalous signal. At the photon energy used (6.0 keV) the
tabulated f 0/f 00 of vanadium is 1.3/3.5 e, and the expected
signal makes a 0.5–0.9% contribution to the structure-factor
amplitudes. This contribution is similar to the situation
reported recently for photosystem II (PSII; Kern et al., 2014; at
7 keV and 4.9 A˚ resolution the expected signal makes a 0.7–
1.0% contribution to the structure-factor amplitudes), which
however has four manganese ions and one calcium ion in the
oxygen-evolving complex, making this effectively a relatively
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Figure 6
Statistics for SFX data from SERCA–Ca2–AMPPCP. (a) Rsplit and (b)
correlation coefficient between random half data sets, CC1/2, against
resolution.
easily detectable superatom at low resolution. The overall
multiplicity of observations was 100 in the case of PSII (3F
data) and 120 in the case of SERC–VO3–TNPATP. This
finding will encourage screening projects in which anomalous
scatterers can be used to identify and analyse ligand-binding
sites, such as in drug discovery.
We expect that ongoing developments in data-analysis
programs such as profile fitting and post-refinement will not
only significantly improve data quality but also reduce the
number of required diffraction patterns and thus the sample
and XFEL beamtime. Indeed, a recent comparison between
data analysis with CrystFEL and nXDS (Kabsch, 2014), which
uses two-dimensional profile fitting for estimating the
observed reflection intensity and subsequent post-refinement
of the correction factors relating each observation to its
unique squared structure-factor amplitude, shows that
comparable data can be obtained using nXDS from far fewer
images (Botha et al., 2015). Moreover, recent developments in
sample-delivery methods such as the use of high-viscosity
extrusion injectors (Weierstall, 2014; Botha et al., 2015) can
greatly reduce sample consumption owing to low flow rates.
They are particularly well suited when the proteins investi-
gated crystallize in the lipidic cubic phase (LCP) or are
compatible with the recently described grease matrix (Suga-
hara et al., 2015).
An additional benefit of liquid jet-based sample delivery is
that the crystals are kept at ambient temperature during SFX
measurements, allowing analysis of the structural distributions
and dynamics under more native conditions. As recently
demonstrated (Fraser et al., 2011), this is important since
structural dynamics and consequently the observed confor-
mations are often temperature-dependent. Thus, monitoring
ambient temperature conformational ensembles by X-ray
crystallography can reveal motions crucial for catalysis, ligand
binding and allosteric regulation (Fraser et al., 2011). This can
be particularly important for proteins that display a wide
range of functionally important conformations such as G-
protein coupled receptors or the P-type ATPases described
here.
In conclusion, our data show that SFX is a valuable
approach for efficient ligand screening with membrane
proteins since a low multiplicity of measurements is sufficient
to identify small features in phased difference electron-density
maps. Our results show that the effective resolution limit of
such data needs to be determined with great care. We strongly
encourage the inclusion of weak high-resolution data reaching
the limit of statistical significance and to empirically test their
influence on the quality of the resulting molecular model to
ensure that no valid data are discarded.
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